BLI International, Inc.

FDA Regulatory Profile

BLI International, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 12 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0029-2025, Class II) was initiated on October 21, 2024.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
12
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0029-2025Class IIChlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI October 21, 2024